TTM
-188.2%
YoY change
+146.88pp
Trough year (2020)
-678.8%
Peak year (2019)
-57.2%
Latest annual
-162.9%
Net Profit Margin history chart for Tango Therapeutics (TNGX) from 2019 to 2025
Latest: -162.9%
Net Profit Margin change chart for Tango Therapeutics (TNGX) from 2019 to 2025
Latest: +146.88pp
Net Profit Margin history table for Tango Therapeutics (TNGX) from 2019 to 2025
| 2025 | -162.9% | +146.88pp | ||
| 2024 | -309.7% | -31.19pp | ||
| 2023 | -278.5% | +156.60pp | ||
| 2022 | -435.1% | -277.93pp | ||
| 2021 | -157.2% | +521.63pp | ||
| 2020 | -678.8% | -621.66pp | ||
| 2019 | -57.2% | — |
- 2025-162.9%+146.88pp
- 2024-309.7%-31.19pp
- 2023-278.5%+156.60pp
- 2022-435.1%-277.93pp
- 2021-157.2%+521.63pp
- 2020-678.8%-621.66pp
- 2019-57.2%—
Net Profit Margin values are taken from Tango Therapeutics's reported income statements (quarterly 10-Q and annual 10-K filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the filing date. YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
About Net Profit Margin at Tango Therapeutics (TNGX)
According to Tango Therapeutics's latest reported financial statements, the company's latest reported net margin is -188.2%. Net profit margin is net income divided by revenue — the bottom-line share of each sales dollar that remains after all costs, including operating expenses, interest, and taxes. It is the most comprehensive profitability ratio, though it can swing on one-off items, so read it alongside the multi-year trend below.
Headline figure above is from the reporting period ending (reported ). Chart and table below cover the full reported history back to .
As of the 2025 fiscal year, Tango Therapeutics (TNGX) reported net margin of -162.85% – expanded 146.9 percentage points year-over-year.
2019 marks the peak net margin at -57.18%, with the historical low of -678.84% recorded in 2020.
Tango Therapeutics Net Profit Margin by Year
Tango Therapeutics Net Profit Margin 2025: -162.9%
2025's net margin for Tango Therapeutics came in at -162.85%, expanded 146.9 percentage points from 2024.
Tango Therapeutics Net Profit Margin 2024: -309.7%
Tango Therapeutics posted net margin of -309.73% in 2024, contracted 31.2 percentage points from 2023.
Tango Therapeutics Net Profit Margin 2023: -278.5%
In 2023, Tango Therapeutics reported net margin of -278.54%, expanded 156.6 percentage points from 2022.
Tango Therapeutics Net Profit Margin 2022: -435.1%
Tango Therapeutics net margin in 2022 was -435.14%, contracted 277.9 percentage points from 2021.
Tango Therapeutics Net Profit Margin 2021: -157.2%
Tango Therapeutics net margin in 2021 was -157.21%.
See more financial history for Tango Therapeutics (TNGX).
Sector peers by Net Profit Margin
Healthcare peers of Tango Therapeutics (TNGX), ranked by their latest net margin
| 37.2% | |
| 35.0% | |
| 21.4% | |
| 20.9% | |
| 17.2% | |
| 13.6% | |
| 5.8% | |
| 2.7% |
- 37.2%
- 35.0%
- 20.9%
- 17.2%
- 13.6%
- 5.8%
Frequently asked questions
Tango Therapeutics (TNGX) Key Financials
Charts, filings, and peer comparison for every metric
Explore more
Deep-dives across the income statement, cash flow, capital return, and valuation